Additionally, HSK31858 rapidly and sustainably reduced the 24-hour sputum volume in patients with bronchiectasis [compared with baseline, the sputum volume decreased by 7.46 g (SE 2.42) in the 20 mg ...

Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Murray et al, Eur Respir J 2009, DOI: 10.1183/09031936.00163208 Colour of phlegm can predict outcomes for patients with ...

Additionally, HSK31858 rapidly and sustainably reduced the 24-hour sputum volume in patients with bronchiectasis [compared with baseline, the sputum volume decreased by 7.46 g (SE 2.42 ...

Bacterial colonisation is an important predictor of exacerbation in AATD-COPD and may require additional targeted therapy, study suggests.

0 Asymptomatic Never diagnosed to have ABPA in the past, presentation with controlled asthma (according to GINA guidelines) and meeting the diagnostic criteria of ABPA (Box 6) 1 Acute Never ...

Find effective medications for 'Bronchiectasis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...

Additionally, HSK31858 rapidly and sustainably reduced the 24-hour sputum volume in patients with bronchiectasis [compared with baseline, the sputum volume decreased by 7.46 g (SE 2.42 ...

Allergic bronchopulmonary aspergillosis is a pulmonary disease occurring in patients with asthma or cystic fibrosis, consequent to a dysregulated immune response to inhaled Aspergillus conidia.